In 2020, Gesynta raised SEK 190 million in one of the year’s largest private biotech investments in the Nordic region. Now the company is one step closer to a new drug for systemic sclerosis. The future promises several innovative treatments for a number of inflammatory diseases, including cardiovascular disease and cancer.
A wireless lung function meter and smartphone app is making life easier for many asthma sufferers. The idea was born in a clinic at Astrid Lindgren Children’s Hospital and now the popular solution is spreading throughout Sweden.
CartaNA’s technology has been described as Google Maps for finding how specific genes are expressed in the body. The technique is set to have a major impact on accelerating the development of new drugs.